Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1075 of 2051 entries
View as:

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Phase: N/A Priority: Normal
NCT ID: NCT01243762 Org: User:
Start: 11/22/10 End: 03/25/13 Due: 03/25/14

Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)

Phase: N/A Priority: Normal
NCT ID: NCT05514444 Org: User:
Start: 09/25/22 End: 03/31/26 Due: 03/31/27

The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)

Phase: N/A Priority: Normal
NCT ID: NCT01832103 Org: User:
Start: 08/31/13 End: 12/31/13 Due: 12/31/14

Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006)

Phase: N/A Priority: Normal
NCT ID: NCT03295266 Org: User:
Start: 12/19/17 End: 03/15/18 Due: 03/15/19

A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00130793 Org: User:
Start: 08/31/05 End: 11/30/05 Due: 11/30/06

Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)

Phase: N/A Priority: Normal
NCT ID: NCT01115712 Org: User:
Start: 05/31/10 End: 09/30/10 Due: 09/30/11

A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)

Phase: N/A Priority: Normal
NCT ID: NCT01709305 Org: User:
Start: 11/08/12 End: 04/17/15 Due: 04/17/16

A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)

Phase: N/A Priority: Normal
NCT ID: NCT06625814 Org: User:
Start: 07/08/24 End: 09/11/24 Due: 09/11/25

Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00482638 Org: User:
Start: 05/12/04 End: 10/29/04 Due: 10/29/05

An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00642798 Org: User:
Start: 03/31/08 End: 03/31/08 Due: 03/31/09

Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00237484 Org: User:
Start: 07/18/05 End: 06/30/11 Due: 06/30/12

Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)

Phase: N/A Priority: Normal
NCT ID: NCT00365378 Org: User:
Start: 09/30/99 End: 07/31/09 Due: 07/31/10

Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)

Phase: N/A Priority: Normal
NCT ID: NCT00535743 Org: User:
Start: 03/04/04 End: 07/20/04 Due: 07/20/05

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00399802 Org: User:
Start: 11/16/06 End: 12/05/07 Due: 12/05/08

V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)

Phase: N/A Priority: Normal
NCT ID: NCT00258154 Org: User:
Start: 02/28/06 End: 11/30/06 Due: 11/30/07

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)

Phase: N/A Priority: Normal
NCT ID: NCT01590771 Org: User:
Start: 07/09/12 End: 06/24/14 Due: 06/24/15

MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)

Phase: N/A Priority: Normal
NCT ID: NCT00082537 Org: User:
Start: 04/30/04 End: 10/31/06 Due: 10/31/07

A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00772967 Org: User:
Start: 06/30/08 End: 11/30/08 Due: 11/30/09

A Study of MK-1167 in Healthy Elderly Participants (MK-1167-004)

Phase: N/A Priority: Normal
NCT ID: NCT06625840 Org: User:
Start: 09/18/23 End: 05/08/24 Due: 05/08/25

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00474370 Org: User:
Start: 05/15/07 End: 10/26/10 Due: 10/26/11

Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)

Phase: N/A Priority: Normal
NCT ID: NCT04425733 Org: User:
Start: 07/07/20 End: 11/10/20 Due: 11/10/21

A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005)

Phase: N/A Priority: Normal
NCT ID: NCT06647628 Org: User:
Start: 11/04/24 End: 03/31/25 Due: 03/31/26

A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)

Phase: N/A Priority: Normal
NCT ID: NCT01241552 Org: User:
Start: 10/10/11 End: 12/09/14 Due: 12/09/15

Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)

Phase: N/A Priority: Normal
NCT ID: NCT00638963 Org: User:
Start: 10/02/08 End: 06/30/10 Due: 06/30/11

Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)

Phase: N/A Priority: Normal
NCT ID: NCT00566527 Org: User:
Start: 11/29/07 End: 12/29/08 Due: 12/29/09